Xu Yuan
- SEC CIK
- 0001858214
No open-market purchases or sales filed in the past year.
Current role at each company
- FATE Fate Therapeutics IncDirectoras of Jun 15, 2026
- XLO Xilio Therapeutics, Inc.Directoras of Jun 12, 2026
- AKRO Akero Therapeutics, Inc.Directoras of Dec 9, 2025
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Xu Yuan as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
FATE Fate Therapeutics Inc
Director3 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Aug 7, 2024 (view filing) | Aug 6 | 1 day | Xu YuanDirector | SSale | −633 | $4.23 | −$2.68K | −6.8%8.67K after | 10b5-1 |
| Aug 7, 2023 (view filing) | Aug 4 | 3 days | Xu YuanDirector | SSale | −632 | $3.71 | −$2.34K | −6.4%9.30K after | 10b5-1 |
| Jun 15, 2023 (view filing) | Jun 14 | 1 day | Xu YuanDirector | SSale | −3.46K | $5.58 | −$19.3K | −25.8%9.93K after | 10b5-1 |